Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has maintained its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ...

Following poor IL-33 data in late May, the company believes that the recent selloff in Regeneron Pharmaceuticals ... for an extremely undervalued AI stock that also stands to benefit significantly ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

This was the stock's second consecutive day of losses.

The stock's fall snapped a two-day winning streak.

Explore Regeneron Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for REGN. Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For ...

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...

Factory Mutual Insurance Co. dramatically upped its stake in Regeneron Pharmaceuticals by 210.3%, acquiring an additional ...

VOO, DIA rise 1% while USO drops 3.6%. - Iran aims to de-escalate after exchanging missile fire with Israel, according to ...

Regeneron Pharmaceuticals took a modest hit as BDF Gestion reduced its stake by 11.5% in the first quarter, now holding $2.8 ...